Table 2.
Mean baseline characteristics of the control and patient cohorts (T2D without complications; T2D with complications). All parameters were determined prior to collection. Data represents mean ± S.E.; *p < 0.05,***p < 0.001, vs. controls. Unless stated, all other characteristics were not significant (p > 0.05).
| Sex [%male] | Age [years] | BMI | blood glucose [mg/dL] | HbA1c [%] | GFR (MDRD) [mL/min] | uACR [mg/g] | |
|---|---|---|---|---|---|---|---|
| Control (15) | 40 | 59.5 ± 7.4 | 27.9 ± 5.2 | 97.1 ± 8.1 | 5.4 ± 0.4 | 94.1 ± 11.9 | 0.6 ± 1.9 |
| T2D without complications (15) | 40 | 64.2 ± 7.3 | 31.2 ± 7.3* | 141.4 ± 37.4* | 7.2 ± 1.3*** | 98.4 ± 20.8 | 0.4 ± 0.9 |
| T2D with complications (15) | 53.3 | 66.4 ± 5.6 | 32.7 ± 5.6* | 161.9 ± 33.3*** | 7.4 ± 0.7*** | 83.0 ± 32.9 | 15.3 ± 22.4* |